A Randomized, Double-Blind, Clinical Trial to Compare the Safety and Efficacy of Cerebrolysin and Aricept (Donepezil) and a Combination Therapy in Patients With Probable Alzheimer's Disease (AD).

Trial Profile

A Randomized, Double-Blind, Clinical Trial to Compare the Safety and Efficacy of Cerebrolysin and Aricept (Donepezil) and a Combination Therapy in Patients With Probable Alzheimer's Disease (AD).

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Apr 2016

At a glance

  • Drugs Brain extract; Donepezil
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors EVER Neuro Pharma
  • Most Recent Events

    • 15 Jul 2010 Results presented at the 2010 International Conference on Alzheimer's Disease and Related Disorders.
    • 12 Sep 2009 Results presented at EFNS 2009.
    • 12 Jul 2009 Tolerability outcomes have been presented at ICAD 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top